Related Experiment Video

Updated: Feb 22, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.9K

Pediatric Myasthenia Gravis

Jason H Peragallo1

  • 1Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.

Seminars in Pediatric Neurology
|September 25, 2017
PubMed

Insights

Juvenile myasthenia gravis (JMG) is an autoimmune disorder causing muscle weakness in children. Diagnosis involves clinical suspicion and tests like antibody levels, while treatment includes medications and potentially surgery.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Myasthenia gravis is a neuromuscular transmission disorder causing muscle fatigue and weakness.
  • In children, myasthenia gravis presents as transient neonatal myasthenia, congenital myasthenic syndromes, or juvenile myasthenia gravis (JMG).
  • JMG is an autoimmune condition often affecting ocular muscles but can lead to generalized weakness and respiratory failure.

Purpose of the Study:

  • To summarize the key aspects of juvenile myasthenia gravis.
  • To outline diagnostic approaches and treatment modalities for JMG.

Main Methods:

  • Clinical suspicion is crucial for diagnosis.
  • Confirmatory tests include serum acetylcholine receptor antibodies, repetitive nerve stimulation, and electromyography.
  • Monitoring for ophthalmological complications like amblyopia is essential.

Main Results:

  • JMG can cause significant skeletal muscle weakness, including respiratory muscles.
  • Diagnostic accuracy is achieved through a combination of clinical evaluation and specific tests.
  • Treatment strategies are multifaceted, addressing the autoimmune and symptomatic aspects.

Conclusions:

  • Juvenile myasthenia gravis requires prompt diagnosis and comprehensive management.
  • Multidisciplinary care, including pediatric ophthalmology, is vital for optimal outcomes.
  • Effective treatments are available, ranging from medications to surgical interventions like thymectomy.

More Related Videos

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

25.7K
Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.8K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.8K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.1K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276